Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas

Mingzhou Guo, Yan Jia, Zhengtao Yu, Michael House, Manel Esteller, Malcolm V. Brock, James G. Herman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Early detection and multi-modality curative treatment for pancreatic cancer remain unsatisfactory due to the insufficient understanding of the mechanisms underlying tumor progression. Epigenetic events, including aberrant methylation of tumor suppressor gene promoter regions, may contribute to tumorigenesis involving both the exocrine and endocrine pancreas. Methylation changes of specific gene promoter regions were examined in 48 resected neoplasms of the exocrine and endocrine pancreas, which were obtained as paraffin-embedded tissue samples. The pancreatic neoplasms included acinar cell carcinoma (n=12), adenocarcinoma (n=18), and islet cell tumors (n=18). DNA methylation was determined with a nested methylation-specific PCR (MSP) technique incorporating an initial bisulfite modification of tumor DNA for the promoter regions associated with 14 tumor suppressor genes. In decreasing order, the 6 most frequently methylated genes were: APC 50%, BRCA1 46%, p16INK4a 35%, p15INK4b 35%, RARβ 35%, and p73 33%. Overall, 94% of the tumors had methylation of at least one gene, and methylation of two or more genes was present in 69% of pancreatic tumors. Pancreatic adenocarcinomas had patterns of gene methylation that differed from pancreatic endocrine tumors. These differences were most notable for the APC and hMLH1 genes.

Original languageEnglish (US)
Pages (from-to)67-73
Number of pages7
JournalDiscovery medicine
Volume17
Issue number92
StatePublished - 2014
Externally publishedYes

Fingerprint

Exocrine Pancreas
Islets of Langerhans
Epigenomics
Methylation
Genetic Promoter Regions
APC Genes
Neoplasms
Tumor Suppressor Genes
Pancreatic Neoplasms
Genes
Adenocarcinoma
Acinar Cell Carcinoma
Islet Cell Adenoma
DNA Methylation
Carcinogens
Paraffin
Carcinogenesis
Polymerase Chain Reaction
DNA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Guo, M., Jia, Y., Yu, Z., House, M., Esteller, M., Brock, M. V., & Herman, J. G. (2014). Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas. Discovery medicine, 17(92), 67-73.

Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas. / Guo, Mingzhou; Jia, Yan; Yu, Zhengtao; House, Michael; Esteller, Manel; Brock, Malcolm V.; Herman, James G.

In: Discovery medicine, Vol. 17, No. 92, 2014, p. 67-73.

Research output: Contribution to journalArticle

Guo, M, Jia, Y, Yu, Z, House, M, Esteller, M, Brock, MV & Herman, JG 2014, 'Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas', Discovery medicine, vol. 17, no. 92, pp. 67-73.
Guo, Mingzhou ; Jia, Yan ; Yu, Zhengtao ; House, Michael ; Esteller, Manel ; Brock, Malcolm V. ; Herman, James G. / Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas. In: Discovery medicine. 2014 ; Vol. 17, No. 92. pp. 67-73.
@article{d0b9774253e9424c91b1ad03965cc06b,
title = "Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas",
abstract = "Early detection and multi-modality curative treatment for pancreatic cancer remain unsatisfactory due to the insufficient understanding of the mechanisms underlying tumor progression. Epigenetic events, including aberrant methylation of tumor suppressor gene promoter regions, may contribute to tumorigenesis involving both the exocrine and endocrine pancreas. Methylation changes of specific gene promoter regions were examined in 48 resected neoplasms of the exocrine and endocrine pancreas, which were obtained as paraffin-embedded tissue samples. The pancreatic neoplasms included acinar cell carcinoma (n=12), adenocarcinoma (n=18), and islet cell tumors (n=18). DNA methylation was determined with a nested methylation-specific PCR (MSP) technique incorporating an initial bisulfite modification of tumor DNA for the promoter regions associated with 14 tumor suppressor genes. In decreasing order, the 6 most frequently methylated genes were: APC 50{\%}, BRCA1 46{\%}, p16INK4a 35{\%}, p15INK4b 35{\%}, RARβ 35{\%}, and p73 33{\%}. Overall, 94{\%} of the tumors had methylation of at least one gene, and methylation of two or more genes was present in 69{\%} of pancreatic tumors. Pancreatic adenocarcinomas had patterns of gene methylation that differed from pancreatic endocrine tumors. These differences were most notable for the APC and hMLH1 genes.",
author = "Mingzhou Guo and Yan Jia and Zhengtao Yu and Michael House and Manel Esteller and Brock, {Malcolm V.} and Herman, {James G.}",
year = "2014",
language = "English (US)",
volume = "17",
pages = "67--73",
journal = "Discovery medicine",
issn = "1539-6509",
publisher = "Discovery Medicine",
number = "92",

}

TY - JOUR

T1 - Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas

AU - Guo, Mingzhou

AU - Jia, Yan

AU - Yu, Zhengtao

AU - House, Michael

AU - Esteller, Manel

AU - Brock, Malcolm V.

AU - Herman, James G.

PY - 2014

Y1 - 2014

N2 - Early detection and multi-modality curative treatment for pancreatic cancer remain unsatisfactory due to the insufficient understanding of the mechanisms underlying tumor progression. Epigenetic events, including aberrant methylation of tumor suppressor gene promoter regions, may contribute to tumorigenesis involving both the exocrine and endocrine pancreas. Methylation changes of specific gene promoter regions were examined in 48 resected neoplasms of the exocrine and endocrine pancreas, which were obtained as paraffin-embedded tissue samples. The pancreatic neoplasms included acinar cell carcinoma (n=12), adenocarcinoma (n=18), and islet cell tumors (n=18). DNA methylation was determined with a nested methylation-specific PCR (MSP) technique incorporating an initial bisulfite modification of tumor DNA for the promoter regions associated with 14 tumor suppressor genes. In decreasing order, the 6 most frequently methylated genes were: APC 50%, BRCA1 46%, p16INK4a 35%, p15INK4b 35%, RARβ 35%, and p73 33%. Overall, 94% of the tumors had methylation of at least one gene, and methylation of two or more genes was present in 69% of pancreatic tumors. Pancreatic adenocarcinomas had patterns of gene methylation that differed from pancreatic endocrine tumors. These differences were most notable for the APC and hMLH1 genes.

AB - Early detection and multi-modality curative treatment for pancreatic cancer remain unsatisfactory due to the insufficient understanding of the mechanisms underlying tumor progression. Epigenetic events, including aberrant methylation of tumor suppressor gene promoter regions, may contribute to tumorigenesis involving both the exocrine and endocrine pancreas. Methylation changes of specific gene promoter regions were examined in 48 resected neoplasms of the exocrine and endocrine pancreas, which were obtained as paraffin-embedded tissue samples. The pancreatic neoplasms included acinar cell carcinoma (n=12), adenocarcinoma (n=18), and islet cell tumors (n=18). DNA methylation was determined with a nested methylation-specific PCR (MSP) technique incorporating an initial bisulfite modification of tumor DNA for the promoter regions associated with 14 tumor suppressor genes. In decreasing order, the 6 most frequently methylated genes were: APC 50%, BRCA1 46%, p16INK4a 35%, p15INK4b 35%, RARβ 35%, and p73 33%. Overall, 94% of the tumors had methylation of at least one gene, and methylation of two or more genes was present in 69% of pancreatic tumors. Pancreatic adenocarcinomas had patterns of gene methylation that differed from pancreatic endocrine tumors. These differences were most notable for the APC and hMLH1 genes.

UR - http://www.scopus.com/inward/record.url?scp=84894481117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894481117&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 67

EP - 73

JO - Discovery medicine

JF - Discovery medicine

SN - 1539-6509

IS - 92

ER -